NEW YORK (Reuters Health) – Once-a-week treatment with long-acting exenatide (Byetta) produces sustained glycemic control and weight loss in diabetics, a multicenter trial has shown. “This study confirms…
NEW YORK (Reuters Health) – Sertraline plus naltrexone is more effective than either agent alone in promoting abstinence in depressed alcohol-dependent patients, according to study findings in the…
NEW YORK (Reuters Health) – Percutaneous tibial nerve stimulation is an effective therapy for overactive bladder symptoms, according to a report in the April issue of The Journal…
NEW YORK (Reuters Health) – In diabetics with heart failure, use of metformin is associated with a lower risk of mortality than use of other anti-diabetic agents, even…
NEW YORK (Reuters Health) – Adjuvant chemotherapy, with or without postoperative radiotherapy, improves survival in patients with operable non-small-cell lung cancer, according to a March 24th online report…
NEW YORK (Reuters Health) – The anticonvulsant topiramate (Topamax) helps treat alcohol dependence, but serious side effects might limit its use, researchers say. In their systematic review, Dr.…
NEW YORK (Reuters Health) – Appropriate use of intravenous narcotics is safe and perhaps even beneficial in patients with acute coronary syndromes, according to Israeli researchers. In general,…
NEW YORK (Reuters Health) – High-potency, stereotactic body radiation therapy (SBRT) may improve survival for patients with medically inoperable early stage lung cancer, results of a multicenter phase…
NEW YORK (Reuters Health) – Urine dipsticks are unreliable and cost-ineffective at screening children for chronic kidney disease, investigators report in the April issue of Pediatrics. In 2007,…
NEW YORK (Reuters Health) – Excisional biopsies are best for diagnosing cutaneous melanoma, because partial biopsies have higher risks of misdiagnosis, adverse events, and microstaging inaccuracy, Australian researchers…
